vimarsana.com

Latest Breaking News On - Neurobo pharmaceuticals inc - Page 8 : vimarsana.com

NeuroBo Submits IND Application For Phase 1 Clinical Trial Of DA-1726; Stock Up In Pre-market

NeuroBo Pharmaceuticals, Inc. (NRBO), a clinical-stage biotechnology company, Thursday said it has submitted Investigational New Drug or IND application to FDA, regarding Phase 1 clinical trial of DA-1726 for the treatment of obesity.

NeuroBo Pharmaceuticals Submits IND Application to the FDA for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.